Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
About
Sinopia Biosciences is a biotechnology company focused on developing novel therapeutics. They leverage their proprietary LEADS® (LEarn And DiScover) drug discovery platform, which utilizes metabolomics-driven discovery capabilities. The company has received a research grant from the National Cancer Institute (NCI) to expand the application of its platform to oncology.
Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
63Traction
39Team
70Visibility
13Profile
40Community
15Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Sinopia Biosciences do?
Sinopia Biosciences is a biotechnology company focused on developing novel therapeutics. They leverage their proprietary LEADS® (LEarn And DiScover) drug discovery platform, which utilizes metabolomics-driven discovery capabilities. The company has received a research grant from the National Cancer Institute (NCI) to expand the application of its platform to oncology.
How much funding has Sinopia Biosciences raised?
Sinopia Biosciences has raised a total of $2M in funding. The most recent round on record is Grant.
Where is Sinopia Biosciences headquartered?
Sinopia Biosciences is headquartered in San Diego, California, USA.
When was Sinopia Biosciences founded?
Sinopia Biosciences was founded in 2017.
What industry does Sinopia Biosciences operate in?
Sinopia Biosciences operates in Biotechnology, Drug Discovery, Oncology, Biotech, AI Drug Discovery, Metabolomics.
Similar Startups